tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jessica Fye, 145 are a HOLD (35.11%), 239 are a BUY (57.87%), 29 are a SELL (7.02%).
Analyst Jessica Fye, currently employed at JPMORGAN, carries an average stock price target met ratio of 72.16% that have a potential upside of 27.69% achieved within 211 days.
Jessica Fye’s has documented 795 price targets and ratings displayed on 56 stocks. The coverage is on Healthcare, Energy, Industrials, Technology sectors.
Most recent stock forecast was given on BMRN, Biomarin Pharmaceutical at 04-Nov-2026.
Analyst best performing recommendations are on APRE (APREA THERAPEUTICS).
The best stock recommendation documented was for ESPR (ESPERION THERAPEUTICS) at 5/3/2018. The price target of $41 was fulfilled within 1 day with a profit of $4.07 (11.02%) receiving and performance score of 110.21.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell Since 06-Jun-2022
$13
$1.39 (11.97%)
2 months 21 days ago
(21-Aug-2026)
2/4 (50%)
$-1.09 (-7.74%)
170
Hold Since 19-Oct-2022
$12
$0.39 (3.36%)
1 years 12 days ago
(30-Oct-2025)
1/3 (33.33%)
$-4.4 (-26.83%)
343
Sell Since 03-Nov-2021
$12
$0.39 (3.36%)
$20
1 years 4 months 17 days ago
(25-Jun-2025)
10/14 (71.43%)
$-4.19 (-25.88%)
92
Buy Since 05-Mar-2021
$100
2 years 4 months 22 days ago
(20-Jun-2024)
12/56 (21.43%)
$62.4 (165.96%)
171
Buy Since 25-Oct-2023
$20
$8.39 (72.27%)
$60
3 years 17 days ago
(25-Oct-2023)
5/26 (19.23%)
$5.72 (40.06%)
73
Which stock is Jessica Fye most bullish on?
Which stock is Jessica Fye most reserved on?
What Year was the first public recommendation made by Jessica Fye?
